Table 1.
Author, Year | Design | Population, N | Fatty Acid(s) | Outcome | Association2 |
---|---|---|---|---|---|
Bone Mineral Density | |||||
Rousseau, 2009 [24] | Cross-sectional, pool of 3 studies | Men & Women >60y N=247 |
Total n-3 Total n-6 Ratio n-6:3 |
Total Femur | + Null Null |
Jarvinen, 2011 [25] | Cross-sectional, Kuopio OSTPRE Fracture Prevention Study | Women Post-menopausal Without HRT N=221 |
Total PUFA Total n-3 Linolenic EPA+DHA Total n-6 LA, AA |
Lumbar Spine | + + + Null + Null |
Farina, 2011 [26] | Cross-sectional, FOP Study | Men & Women Mean age 75y N=854 |
ALA, EPA, DHA LA, AA n6:n3 ratio |
Femoral Neck | Null Null Null |
Farina, 2012 [27] | Cross-sectional, FOP Study | Men Mean age 75y N=484 |
Plasma: DHA LA AA |
Femoral Neck | Null Null - |
Virtanen, 2010 [28] | Cross-sectional, Cardiovascular Health Study | Men & Women Mean age 73y N=1,305 |
Fish EPA + DHA |
Femoral Neck | Null Null |
Farina, 2011 [26] | Longitudinal, FOP Study | Men Mean age 75y N=623 |
ALA EPA, DHA EPA+DHA LA AA n6:n3 ratio |
Femoral Neck 4y change | Maintenance Lost less (+) Lost less (+) Maintenance Lost less (+) Maintenance |
Farina, 2012 [27] | Longitudinal, FOP Study | Men Mean age 75y N=363 |
Plasma: DHA LA AA |
Femoral Neck, 4y change | Lost less (+) Null Null |
Lappe, 2013 [32] | Randomized Controlled Trial 6mo | Post-menopausal women N=58 |
Intervention: 1g PUFA (DHA&EPA)* Control: corn oil & beeswax |
Lumbar Spine Femoral Neck Wards triangle Trochanter Total Hip Whole Body |
Null Maintenance + Null Null Null |
Risk of Fracture | |||||
Fan, 2013 [38] | Matched Case-Control | Men & Women Mean age 71y 581 cases |
Selected fish intake | Risk of Hip Fracture | Risk (+) |
Farina, 2012 [27] | Longitudinal (17y FU), FOP Study | Men & Women Mean age 75y N=765 |
Plasma: DHA LA AA |
Risk of Hip Fracture | Null Null Risk (+) |
Farina, 2011 [35] | Longitudinal (11y FU), FOP Study | Men & Women Mean age 75y N=904 |
ALA EPA, DHA EPA + DHA Linoleic acid AA n6:n3 ratio Fish |
Risk of Hip Fracture |
Risk (+) Null Null Null Risk (+)** Null Null |
Virtanen, 2010 [28] | Longitudinal, (11y FU) Cardiovascular Health Study |
Men and Women Mean age 73y N=5,045 |
Tuna + other fish EPA + DHA |
Risk of Hip Fracture | Null Null |
Virtanen, 2012 [37] | Longitudinal, (24y FU) Pooled from: NHS Study & Health Professional Follow up Study |
Men & Women Mean age 63y N=122,354 |
Total PUFA Total n-3 ALA, EPA+DHA Total n-6 LA Fish |
Risk of Hip Fracture | Null Null Null Null Null Null |
Orchard, 2010 [36] | Longitudinal, (7.8y FU) Woman’s Health Initiative |
Post-menopausal women N=137,486 |
PUFA Total n-3 ALA, EPA+DHA Total n-6 |
Risk of Hip Fracture | Null Null Null Null |
Markers of Bone Turnover | |||||
Salari, 2010 [34] | Randomized Controlled Trial 6mo | Post-menopausal women N=25 |
900mg n-3 vs. Placebo | OC, BAP Urine Pyd |
Null Null (+) |
Martin-Bautista, 2010 [33] | Randomized Controlled Trial 12mo | Hyperlipidemic adults N=72 |
Fortified milk (0.2g EPA + 0.14g DHA + 5.17g oleic acid), 250ml 2x/d vs.Placebo milk | OPG RANKL OPG/RANKL PTH, CTX OC |
(+) (+) (+) Null (+) |
Lappe, 2013 [32] | Randomized Controlled Trial 6mo | Post-menopausal women N=58 |
1g PUFA (DHA&EPA) 3 vs. Placebo | BAP NTx OC, DPD, OPG, RANKL |
(+) (+) Null Null |
Abbreviations used: FOP Study, Framingham Osteoporosis Study; PUFA, polyunsaturated fatty acids; n-3 FA, omega 3 fatty acids; n-6 FA, omega 6 fatty acids; LA, linoleic acid; ALA, alpha-linolenic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; AA, arachidonic acid; FU, follow-up; OC, osteocalcin; BAP, bone-specific alkaline phosphatase; urine Pyd, urinary pyridinoline; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor kappa-B ligand; PTH, parathyroid hormone; CTX, serum collagen type 1 cross-linked C-telopeptide; NTx, urinary N-telopeptide; DPD, urinary free deoxypyridinoline; NHS, Nurses Health Study
+ denotes a positive relation with bone; - denotes a negative association with bone health.
Intervention also included 30mg genistein + 800IU vitamin D3 + 150μg vitamin K1; EPA:DHA ratio of 2:1.
Results observed in men only